WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 32.92
+1.60 (5.11%)
Aug 22, 2025, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 134.00 billion as of August 22, 2025. Its market cap has increased by 180.19% in one year.
Market Cap
134.00B
Enterprise Value
130.36B
Revenue
21.98B
Ranking
n/a
PE Ratio
30.39
Stock Price
32.92
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 134.00B, an increase of 318.25%. That is a compound annual growth rate of 19.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 134.00B | 85.85% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | 419.91B | 228.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.89B |
| Hansoh Pharmaceutical Group Company | 217.86B |
| JD Health International | 206.25B |
| Innovent Biologics | 170.08B |
| Akeso | 150.79B |
| Sino Biopharmaceutical | 138.07B |
| CSPC Pharmaceutical Group | 119.93B |
| Sichuan Kelun-Biotech Biopharmaceutical | 103.71B |